The Ensign (ENSG)
NASDAQ:ENSG
Want to see ENSG full AI Analyst Report?
ENSG Stock Chart & Stats
$200.11
$0.93(0.71%)
At close: 4:00 PM EST
$200.11
$0.93(0.71%)
Day’s Range― - ―
52-Week Range$134.80 - $218.00
Previous CloseN/A
Volume60.10K
Average Volume (3M)668.76K
Market Cap
$8.60B
Enterprise Value$11.50B
Total Cash (Recent Filing)$595.17M
Total Debt (Recent Filing)$2.24B
Price to Earnings (P/E)23.4
Beta0.17
Next Earnings
Jul 23, 2026EPS Estimate
1.85Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)6.33
Shares Outstanding58,445,400
10 Day Avg. Volume831,839
30 Day Avg. Volume668,759
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)4.47
Price to Sales (P/S)1.97
P/FCF Ratio26.93
Enterprise Value/Market Cap1.34
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit15.65
Enterprise Value/Ebitda19.35
Forecast
1Y Price Target
$218.50Price Target Upside9.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)7.52
Revenue Forecast (FY)$5.83B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthEnsign's multi-year revenue expansion reflects a durable roll-up strategy and organic demand in post-acute care. Consistent top-line growth, supported by both acquisitions and same-store momentum, underpins scalable operations and provides a larger base to absorb costs and fund future investments.
Improved Liquidity & Balanced LeverageMeaningful liquidity and modest leverage position the company to pursue acquisitions and weather reimbursement variability. Strong cash balances plus committed revolver capacity and disciplined lease-adjusted leverage give management financial flexibility to execute M&A and invest in operations.
High Clinical Quality & Operational GainsConsistently high clinical scores and documented facility turnarounds indicate sustainable operational advantages. Superior quality metrics support payor confidence, referral volumes, and reimbursement mix, and reduce downside from regulatory scrutiny relative to lower-quality peers.
Bears Say
Margin Compression And Cash ConversionProfitability has weakened from earlier peaks and FCF converts a smaller share of earnings, implying operational or working-capital pressure. Persistent margin erosion and uneven cash conversion could constrain reinvestment, M&A payback timelines, and debt servicing under adverse conditions.
Historic Leverage VolatilityAlthough recent leverage metrics improved, material year-to-year swings (notably 2025) show balance-sheet sensitivity to acquisition and financing cycles. This volatility raises refinancing and covenant risks during downturns and makes long-term capital planning and cost of capital less predictable.
Regulatory & Reputational Scrutiny RiskAllegations of substandard care and amplified managed-care/clinical reviews create structural regulatory and reputational risk. Sustained scrutiny could prompt audits, slower reimbursement, or state actions that materially alter revenue and operating dynamics across the portfolio over the medium term.
The Ensign Group News
ENSG FAQ
What was The Ensign’s price range in the past 12 months?
The Ensign lowest stock price was $134.79 and its highest was $218.00 in the past 12 months.
What is The Ensign’s market cap?
The Ensign’s market cap is $8.60B.
When is The Ensign’s upcoming earnings report date?
The Ensign’s upcoming earnings report date is Jul 23, 2026 which is in 41 days.
How were The Ensign’s earnings last quarter?
The Ensign released its earnings results on Apr 30, 2026. The company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.817 by $0.033.
Is The Ensign overvalued?
According to Wall Street analysts The Ensign’s price is currently Undervalued.
Does The Ensign pay dividends?
The Ensign pays a Quarterly dividend of $0.065 which represents an annual dividend yield of 0.14%. See more information on The Ensign dividends here
What is The Ensign’s EPS estimate?
The Ensign’s EPS estimate is 1.85.
How many shares outstanding does The Ensign have?
The Ensign has 58,445,400 shares outstanding.
What happened to The Ensign’s price movement after its last earnings report?
The Ensign reported an EPS of $1.85 in its last earnings report, beating expectations of $1.817. Following the earnings report the stock price went down -1.591%.
Which hedge fund is a major shareholder of The Ensign?
Currently, no hedge funds are holding shares in ENSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The Ensign Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$218.50 (9.19% Upside)
$218.50 (9.19% Upside)
Blogger Sentiment
Bullish
ENSG Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 257.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Very Bearish
Bullish news 19%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.41%
12-Months-Change
Fundamentals
Return on Equity
16.63%
Trailing 12-Months
Asset Growth
17.90%
Trailing 12-Months
Company Description
The Ensign
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
ENSG Company Deck
ENSG Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed multiple strong operational and financial positives: record occupancy, meaningful year-over-year revenue and EPS growth, raised guidance, disciplined balance sheet with ample liquidity, accelerating M&A and strong clinical outcomes across the portfolio. Lowlights were largely forward-looking risks and transitional items (ERP implementation, short-term EPS drag from turnaround deals, seasonality and potential state budget uncertainty) rather than current performance shortfalls. Overall the positive items materially outweigh the manageable and disclosed risks.View all ENSG earnings summariesENSG Stock 12 Month Forecast
Average Price Target
$218.50
▲(9.19% Upside)
Technical Analysis
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Surgery Partners
―
Ownership Overview
1.55% Insiders
33.69% Mutual Funds
31.18% Other Institutional Investors
10.69% Public Companies and
Individual Investors